Drug Topics
JULY 2, 2025
In an interview, Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, professor of practice, sciences, and health outcomes research at the University of Maryland, explored the evolving landscape of vaccine recommendations, emphasizing the critical role pharmacists play in guiding patients through complex medical information.
Drug Topics
JULY 6, 2025
In an interview on vaccine recommendations, health care professionals expressed growing concerns about the changing landscape of medical information dissemination. In an interview on vaccine recommendations, health care professionals expressed growing concerns about the changing landscape of medical information dissemination.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 6, 2025
However, a new study published in Gastroenterology Nursing shows that although videos on IBD have millions of views, the videos score low for quality of medical information. 5 The study authors stated, “TikTok offers a space for individuals with IBD to share information and experiences. 1 REFERENCES 1.
Drug Topics
JUNE 19, 2025
The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The FDA approved nitisinone (Harliku) for the reduction of urine homogentisic acid (HGA) in patients with alkaptonuria (AKU). The medication is expected to launch in July 2025. REFERENCES 1.
Drug Topics
JULY 21, 2025
The FDA approved insulin aspart-xjhz (Kirsty) 100 units/mL as the first and only interchangeable biosimilar to insulin aspart (NovoLog). 1 The FDA approves Kirsty, an interchangeable biosimilar insulin, enhancing diabetes treatment options and accessibility for patients. Sign up today for our free Drug Topics newsletter.
Drug Topics
JUNE 9, 2025
The FDA approved telmisartan, amlodipine and indapamide (Widaplik) for the treatment of hypertension in adult patients, George Medicines said in a release. The FDA approved telmisartan, amlodipine and indapamide (Widaplik) for the treatment of hypertension in adult patients, George Medicines said in a release. References 1.
Drug Topics
JULY 16, 2025
1 READ MORE: HIV Resource Center Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips. Sign up today for our free Drug Topics newsletter.
Expert insights. Personalized for you.
Let's personalize your content